← All Kronos Bio, INC filings

Kronos Bio, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

KRON
Kronos Bio, INC
DEFA14A: Kronos Bio Appoints Deborah Knobelman as CFO and COO, Replacing Sandra Gardiner
Kronos Bio announces the appointment of Deborah Knobelman as Chief Financial Officer and Chief Operations Officer, effective June 3, 2024, replacing Sandra Gardiner.
KRON
Kronos Bio, INC
DEFA14A: Kronos Bio, Inc. Files Definitive Proxy Statement
Kronos Bio, Inc. has filed a definitive proxy statement with the SEC.
KRON
Kronos Bio, INC
DEF 14A: Kronos Bio Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Kronos Bio will hold its 2024 Annual Meeting of Stockholders virtually on June 25, 2024, to vote on the election of directors, executive compensation, and the ratification of its independent accounting firm.